IL-12-mediated transcriptional regulation of matrix metalloproteinases

Biosci Rep. 2018 Jun 12;38(3):BSR20171420. doi: 10.1042/BSR20171420. Print 2018 Jun 29.

Abstract

Matrix metalloproteinases (MMPs) are extracellular matrix (ECM) remodelling enzymes involved in developmental processes, tissue remodelling and repair, inflammatory and immune diseases and cancer. In a recent issue of Bioscience Reports (vol. 37, issue 6, BSR20170973), Liu and colleagues investigated the expression of MMPs such as MMP-1 (interstitial collagenase), MMP-3 (stromelysin 1) and MMP-13 (collagenase 3) in human periodontal ligament fibroblasts (hPDLFs) regulated by interleukin-12 (IL-12), a cytokine implicated in inflammatory and immune responses. They showed that IL-12 activates canonical nuclear factor-κB (NF-κB) signalling leading to increased expression of MMP-1, MMP-3 and MMP-13, and to a smaller reduction in the expression of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) at both mRNA and protein levels, with corresponding changes in the secreted levels of these ECM-remodelling and immune regulatory metalloproteinases. While canonical NF-κB signalling regulates these MMPs, it also interacts with additional factors to determine whether some of these MMPs are induced or downregulated, in response to IL-12. Here, we comment on the possible mechanisms of IL-12-mediated transcriptional regulation of MMPs.

Keywords: Cytokines; IL-12; Matrix metalloproteinases; nuclear factor kappaB.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Fibroblasts / enzymology
  • Humans
  • Interleukin-12
  • Matrix Metalloproteinase 12*
  • NF-kappa B
  • Periodontal Ligament / enzymology*

Substances

  • NF-kappa B
  • Interleukin-12
  • Matrix Metalloproteinase 12